Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intestinal Inflammation in Ankylosing Spondylitis Assessed by Fecal Calprotectin, Capsular Endoscopy and Colonoscopy and the Effects of Adalimumab on Mucosal Healing

NCT01174186 is registered in ClinicalTrials.gov with Regionshospitalet Silkeborg as lead sponsor.

NCT NCT01174186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01174186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intestinal Inflammation in Ankylosing Spondylitis Assessed by Fecal Calprotectin, Capsular Endoscopy and Colonoscopy and the Effects of Adalimumab on Mucosal Healing
Lead sponsor
Regionshospitalet Silkeborg
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2010
Completion date
March 31, 2014
Enrollment
30 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

enterocolitis, spondyloarthritis